HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance.
Nagao A, Kobayashi M, Koyasu S, Chow CCT, Harada H. · 2019
Read HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance. by Nagao A, Kobayashi M, Koyasu S, Chow CCT, Harada H. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6359724.txt.
Description
Nagao and co-authors present a review in the International Journal of Molecular Sciences on how cancer cells rewire glucose use. The focus is HIF-1, a protein that helps cells respond to low oxygen. The authors explain how HIF-1 drives the Warburg effect, where tumors favor fast glycolysis even when oxygen is present.
The review covers how HIF-1 turns on glycolysis and a linked pathway that supplies building blocks for growth. It also links this metabolic shift to antioxidant defenses and resistance to radiation. The authors add their own findings on a factor that raises HIF-1 activity in cancer cells. Readers get a clear map of these pathways and of possible treatment targets.
Catalog record
| CREATOR | Nagao A, Kobayashi M, Koyasu S, Chow CCT, Harada H. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |